Clinical Trial Update: A Pharmaco-imaging Approach to Predicting Social Functioning and Clinical Responses to Oxytocin Administration in Schizophrenia [Phase 2]

View source ↗

Summary

This Phase 2 trial investigated oxytocin's effects in schizophrenia using pharmaco-imaging to predict social functioning and clinical response. The study was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Schizophrenia | Phase 2 | Status: TERMINATED | Results posted: 2026-01-20